These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21694730)
21. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step. Barbouche R; Decroly E; Kieny MP; Fenouillet E Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419 [TBL] [Abstract][Full Text] [Related]
23. Glu659Leu substitution of recombinant HIV fusion inhibitor C52L induces soluble expression in Escherichia coli with equivalent anti-HIV potency. Shang S; Tan S; Li K; Wu J; Lin H; Liu S; Deng Y Protein Eng Des Sel; 2011 Jul; 24(7):545-51. PubMed ID: 21478177 [TBL] [Abstract][Full Text] [Related]
24. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure. Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108 [TBL] [Abstract][Full Text] [Related]
25. Peculiarity in crystal packing of anti-HIV lectin actinohivin in complex with α(1-2)mannobiose. Suzuki K; Tsunoda M; Hoque MM; Zhang F; Jiang J; Zhang X; Ohbayashi N; Tanaka H; Takénaka A Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1818-25. PubMed ID: 23999305 [TBL] [Abstract][Full Text] [Related]
26. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells. Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806 [TBL] [Abstract][Full Text] [Related]
28. SUMO fusion facilitates expression and purification of garlic leaf lectin but modifies some of its properties. Upadhyay SK; Saurabh S; Rai P; Singh R; Chandrashekar K; Verma PC; Singh PK; Tuli R J Biotechnol; 2010 Mar; 146(1-2):1-8. PubMed ID: 20100526 [TBL] [Abstract][Full Text] [Related]
29. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12. Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430 [TBL] [Abstract][Full Text] [Related]
30. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins. Astoul CH; Peumans WJ; Van Damme EJ; Roug Biochem Biophys Res Commun; 2000 Aug; 274(2):455-60. PubMed ID: 10913359 [TBL] [Abstract][Full Text] [Related]
32. Selection and characterization of an HIV-1 gp120-binding affibody ligand. Wikman M; Rowcliffe E; Friedman M; Henning P; Lindholm L; Olofsson S; Ståhl S Biotechnol Appl Biochem; 2006 Sep; 45(Pt 2):93-105. PubMed ID: 16712522 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120. Favero J; Corbeau P; Nicolas M; Benkirane M; Travé G; Dixon JF; Aucouturier P; Rasheed S; Parker JW; Liautard JP Eur J Immunol; 1993 Jan; 23(1):179-85. PubMed ID: 8419169 [TBL] [Abstract][Full Text] [Related]
34. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry. Roda Rani KP; Pelluru D; Kondapi AK Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922 [TBL] [Abstract][Full Text] [Related]
35. Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein. Mori T; Shoemaker RH; Gulakowski RJ; Krepps BL; McMahon JB; Gustafson KR; Pannell LK; Boyd MR Biochem Biophys Res Commun; 1997 Sep; 238(1):218-22. PubMed ID: 9299482 [TBL] [Abstract][Full Text] [Related]
38. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes. Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023 [TBL] [Abstract][Full Text] [Related]
39. Angiogenin single-chain immunofusions: influence of peptide linkers and spacers between fusion protein domains. Newton DL; Xue Y; Olson KA; Fett JW; Rybak SM Biochemistry; 1996 Jan; 35(2):545-53. PubMed ID: 8555226 [TBL] [Abstract][Full Text] [Related]
40. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope. Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]